Skip to main content
European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

PROPOSAL FOR FUNDING RESEARCH DEVELOPMENT AND MANUFACTURING OF VACCINE AGAINST COVID-19

Opis projektu

Finansowanie szczepionki CEPI przeciwko COVID-19

W sytuacji, gdy pandemia COVID-19 zagraża życiu miliardów ludzi, zbierając przy tym ekonomiczne żniwo na całym świecie, niektórzy w pocie czoła pracują nad wynalezieniem szczepionki przeciwko tej chorobie. Zważywszy na zatrważające doniesienia ze świata, mówiące o milionach zgonów, starania na rzecz opracowania szczepionki mają szczególnie duże znaczenie. Dlatego też celem finansowanego ze środków UE projektu COVID-19 VACCINES jest pozyskanie przez organizację Coalition for Epidemic Preparedness Innovations (CEPI) środków od Komisji Europejskiej na sfinansowanie badań nad szczepionką. CEPI zajmuje się wyszukiwaniem programów badawczo-rozwojowych, w ramach których opracowuje się nowe szczepionki po to, aby zwiększyć dostęp do szczepień dla jak największej liczby ludzi na świecie.

Cel

Funding of research and innovation programmes for the development of novel SARS-CoV-2 vaccine against COVID-19 disease

The overall objective is to leverage co-funding from the European Commission to support CEPI’s COVID-19 vaccine programme development efforts. The COVID-19 outbreak has in a short timeframe grown to a global pandemic of historic proportions, with detrimental humanitarian and economic consequences. All evidence now suggests that eradication of COVID-19 is not feasible and that we face a global public health crisis which is unprecedented in modern times. Investing in vaccine development now is an investment in the future health for all in our societies and a return to social and economic development – both in Europe and in the rest of the globe.
CEPI is seeking to support scientifically excellent research and development vaccine development programmes of a nature that will allow the broadest global access of the vaccines that are ultimately developed both within the current pandemic crisis and beyond. This will help curb the current ongoing outbreak, that is resulting in human suffering and a grave global economic crisis. CEPI was set up to respond to the crisis, where our vision is a world in which epidemics are no longer a threat to humanity. Our strategic objectives are further aligned with the sustainable
development goals 3, 8 and 17. Of particular importance to CEPI’s work is to try and ensure that low- and low-middle income countries (LICs and LMICs, respectively) will have access to the vaccines to protect their most vulnerable population, as soon as a vaccine is made available and irrespective of their ability to pay. As the current pandemic has shown, viruses respect no borders. To successfully curb the COVID-19 pandemic and beyond, we must ensure that all countries have the necessary tools to control the outbreak domestically. No-one is safe until everyone is safe.

Zaproszenie do składania wniosków

H2020-FPA-SGA-SC1-CEPI-2019

Zobacz inne projekty w ramach tego zaproszenia

Szczegółowe działanie

H2020-SGA-SC1-CEPI-2020

Koordynator

COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS
Wkład UE netto
€ 100 000 000,00
Adres
SKOYEN ATRIUM ASKEKROKEN 11
0277 OSLO
Norwegia

Zobacz na mapie

Region
Norge Oslo og Viken Oslo
Rodzaj działalności
Research Organisations
Linki
Koszt całkowity
€ 150 000 000,00